Introduction
Rheumatoid arthritis (RA) is a chronic debilitating inflammatory autoimmune disease involving articular cartilage. Recent observations suggest that RA may not be a single disease but a collection of syndromes. Many cellular and molecular factors contribute to the pathogenesis of this complex disease.
Cytokines play a prominent role in RA and their complex interactions in RA development are only just starting to be discovered. The proinflammatory cytokines TNF-α and IL-1 are critical mediators in the inflammatory process of arthritis [1, 2] and neutralizing these effector cytokines have proven successful in treatment of RA.
The CD4+ T helper cell response is classically compartmentalized into Th1
and Th2 responses [3] . Th1 cells produce IL-2, IFN-γ and IL-12 and contribute mainly to cellular immunity. Th2 cells produce cytokines such as IL-4, IL-5, and IL-13 and support IgG1 and IgE antibody production, and the underlying humoral immunity. The classification of Th1/ Th2 dichotomy has provided a framework in which to compare types of immune responses. However, this segregation of immune responses has also lead to oversimplification of the autoimmune diseases into either Th1 or Th2 type. The inflammatory process in RA has been suggested to be promoted by Th1 cytokines whereas Th2 cytokines might suppress the disease [4] . This assumption was supported by the regulatory effect of Th2 cytokines on Th1 activity [5] . Furthermore, Th2 cytokines modulated macrophage function and protected subchondral bone erosion and cartilage damage by delaying differentiation of osteoclasts [6] , possibly through osteoprotegrin ligand-mediated mechanisms [7] . Therapeutic strategies by blocking Th1 cytokine IFN-γ have also been initiated in RA patients [8] . However, these assumptions have been challenged because disease mechanisms in reality are very complex [9] . Hence, there is a need for animal models that are able to delineate the role of these cytokines in the arthritis disease process.
Th2 cytokine, IL-4 is multifunctional [10] and has been shown to induce expression of MHC class II molecules on B cells, activate mast cells, mediate
Th2 cell commitment and survival, and induce Ig class switching to IgG1 and IgE. IL-4 is believed to exhibit its anti-inflammatory effects by suppression of macrophage functions such as IL-1, TNF-α and NO production [11, 12] and could suppress synoviocyte proliferation [13] . Moreover, IL-4 stimulates the synthesis of several cytokine inhibitors such as interleukin-1 receptor antagonist (IL-1Ra), IL-1-receptor type II and TNF receptors [11, 12, 14] . In addition, IL-4 inhibits both osteoclast activity and survival, and thereby blocks bone resorption in vitro [6] .
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Using recombinant IL-4 and adenovirus gene therapy, suppression of early events of collagen induced arthritis and proteoglycan induced arthritis were observed [15] [16] [17] [18] . But, the suppressive effect is not substantial, however, in some cases the effect could be enhanced by a combination strategy [15, 19] .
Most of the studies involving amelioration of arthritis with IL-4 showed that this cytokine reduced the level of anti-CII antibody production [16, 17, 20, 21] suggesting that the arthritis suppressing effect of IL-4 could possibly be explained at the level of antibody synthesis in these studies. Alternatively, IL-4 could operate on several levels in the arthritis process [19] . Earlier, we demonstrated that IL-4 actually plays different roles depending on the type of adjuvant used and the phase (acute vs chronic) of the clinical disease. Our results, in a variant of CIA mouse model, indeed suggested that IL-4 deficiency had a promoting effect on development of disease relapses [22] , although we also noted a pronounced protection from arthritis during the early severe stages. Hence, it is of interest to understand whether IL-4 deficiency can actually promote antibody mediated inflammation in vivo, which is believed to be the major pathogenic inflammatory pathway during acute CIA.
Collagen antibody induced arthritis (CAIA) is now extensively used to study the inflammatory phase of arthritis. Antibody-mediated arthritis is dependent on FcγR [23] and complement [24] but not B or T cells [25] , with neutrophils 6 and macrophages being the major mediators of this inflammation [26] . The CAIA mouse model provides an opportunity to study the inflammation phase without involving the priming phase of the immune response. Hence, we used this model to gain an understanding how IL-4 regulates the inflammatory process, which may prove essential for designing effective therapeutic interventions for RA.
Results
BALB/c mice developed more severe arthritis than C57BL/6 mice BALB/c mice are believed to have a genetic predisposition towards Th2 responses [27] compared to the Th1 cytokine milieu prevalent in C57BL/6 mice. Arthritis induced with CII specific monoclonal antibodies in various mouse strains demonstrated genetic heterogeneity in the development of inflammatory phase of the joint disease [26] . As shown in Table 1 , BALB/c mice developed more severe CAIA (32.9±3.0) with higher incidence (100%) than the C57BL/6 mice (2.3±0.3; 21%). This observation raised the possibility for a pro-inflammatory role of the Th2 cytokines.
Stat6 but not Stat4 deficient mice are relatively resistant to CAIA
In order to confirm our hypothesis that the anti-inflammatory Th2 cytokines might actually promote arthritis at the effector phase, we compared CAIA 7 susceptibility between Stat6 and Stat4 deficient mice. Stat6 deficient mice are known to be unable to mount a Th2 response whereas Stat4 deficient mice are unable to mount a Th1 response. In concordance to our hypothesis, Stat 6 mice had less severe arthritis than the Stat 4 mice both before and after LPS injection (LPS injection promotes incidence and severity of antibody initiated arthritis) (Figure 1 ). However, during the later phase of the disease, arthritis score declined rapidly in Stat4 but not in Stat6 deficient mice.
IL-4 deficient mice are less prone to collagen antibody mediated arthritis
To directly address the question, whether the Th2 cytokine IL-4 has arthritis promoting effect, we tested CAIA in both the IL-4 deficient and sufficient mice on the B10.RIII background. In the two similar experiments, with several animals in each group, 63-67% of IL-4 sufficient and 13-20% of IL-4 deficient animals developed arthritis (P≤ 0.0275). We consistently found that IL-4 deficiency significantly suppressed the incidence of the antibody-induced arthritis ( Figure 2) . However, the used IL-4 gene deficient animals also had linked genes originating from the embryonic stem cells. Thus, although the mice were backcrossed to C57Bl/10 for 13 generations, they still had a 12.7 cM of 129-linked fragment on chromosome 11. Nevertheless, there were no IL-4 spots observed in the Con A-stimulated lymph node cultures from IL-4 deficient animals in the ELISPOT assay [22] . On the other hand, this does not exclude the influence of another 129 gene; therefore to confirm and clarify our findings, we decided to deplete IL-4 using 11B11 antibodies in the naïve B10.RIII mice in the CAIA experiment. We found that the IL-4 depleted mice had significantly reduced incidence of arthritis induced by the anti-CII antibodies (Figure 3 
IL-1R and IL-1RTNF-R deficient mice are resistant to CAIA
Previous studies demonstrated that IFN-γ deficient mice have up regulated levels of interleukin-1β but not TNF-α and IL-6. Furthermore, TNF-α and IL-1 but not IL-6 have been shown to be important in CAIA [32] . Here, we confirmed these findings using IL1-R and IL-1RTNFR deficient mice, which were totally resistant to CAIA induction using our set of anti-CII monoclonal antibodies ( Figure 5 ).
Discussion

IL-4 is produced by T cells, mast cells and bone marrow stromal cells and is
perceived as an anti-inflammatory cytokine; however, under certain circumstances IL-4 may function as a pro-inflammatory cytokine. In the present investigation, for the first time we show that genetic deletion or antibody neutralization of the anti-inflammatory Th2 cytokine IL-4 increased the resistance to develop collagen antibody induced arthritis (CAIA).
Infiltrating cells in the paws of IL-4 sufficient but not deficient mice showed increased osteoclast activity and TNF-α secretion. Massive infiltration of granulocytes, joint and cartilage damage were observed in the arthritic paws.
Anti-IL-4 mediated suppression of the inflammatory arthritis was abrogated by IFN-γ depletion. Similarly, stat6 deficient mice that are unable to mount Th2 responses were resistant to arthritis after antibody transfer compared to Stat4 deficient mice. Even after the secondary stimulus LPS injection that enhances the arthritis incidence and severity [26] , stat6 deficient mice showed significantly less severe arthritis compared to stat4 deficient mice.
Interestingly, IL-1R and IL-1RTNFR deficient mice were completely resistant to CAIA.
Similar to our present observations, when the function of IL4 was neutralized either by antibody administration or genetic ablation the onset and severity of CIA were greatly reduced [22, 33] . Furthermore, DBA/1 mice expressing an IL-2Rβ/IL-4R chimeric transgene showed similar results. In these mice, IL-2 binding of the receptor transmits a signal via the IL-4 pathway [34] . Arthritis developed in these chimeric transgenic mice at an accelerated rate with increased severity. The autoimmune disease was associated with an increase in type 2 cytokines (IL-4, IL-5, IL-10). Earlier, we also found that IL-4 plays different roles depending on the type of adjuvant used in CIA and the phase (acute or chronic) of the clinical disease [22] . Despite the protective effect against cartilage erosions, local delivery of adenoviral vector containing IL-4 actually increased the inflammation in collagen-induced arthritis [35] . Antibody induced arthritis develops also in the absence of B and T cells [25] , however we do not exclude a modulatory role of T cells in CAIA. In this inflammatory process, it is possible that the effect of anti-IL-4 treatment and /or the anti-IFN-γ co-treatment could be due to an effect on neutrophils, macrophages or other effector cells [26] . Alternatively, regulation of proinflammatory cytokines like TNF-α and IL-1β which are known to be involved in the antibody-mediated disease [32] could also be important in this situation.
Interestingly, the suppression of arthritis mediated by neutralization of IL-4 is dependent on IFN-γ, since co-treatment of these mice with neutralizing anti-IFN-γ mAb abolished the suppressive effect of anti-IL-4. It has long been recognized that IFN-γ is one of the major macrophage activation factors.
However, it is possible that macrophage activation factors other than IFN-γ or contact mediated macrophage activation might also be involved in the anti-IL4 mediated inhibition of antibody mediated inflammation.
Like RA, the inflammatory response in the arthritic mouse joint is predominantly mediated by the pro-inflammatory cytokines TNF-α and IL-1
[31], all of which have been successfully targeted to down-regulate the disease 14 [36] . Up regulation of IL-1β but not TNFα and IL-6 expression has been observed in the IFN-γ deficient C57BL/6 mice enabling the CIA induction in the non-susceptible mouse strain [37] . Similar results have been reported using IFN-γ deficient mice in other models of autoimmunity in which susceptibility to autoimmunity was enhanced by preventing the effects of IFN-γ [38] .
Furthermore, mice lacking IFN-γ receptors were also found to be highly susceptible to CIA [39, 40] . This concept is supported by the observations that IFN-γ has been shown to be efficient in the treatment of RA [8] and that IFN-γ production is diminished in peripheral blood and in synovial fluid lymphocytes of RA patients [41] . Hence, in the present study it is possible that the depletion of IFN-γ might have increased pro-inflammatory cytokines such as IL-1β, which plays a prominent role in the inflammation of both RA patients as well as in animal models of autoimmune arthritis. Recent studies also suggest a distinct role for IL-17 in the absence of IL-4 and IFN-γ [42] . However, since the role of IFN-γ is very complex under inflammatory conditions, several reproducible studies are needed to evaluate the efficacy of IFN-γ before treating RA patients with anti-IFN-γ therapy.
In the mouse model, administration of IL-1-β readily accelerates the development of CIA in genetically susceptible strains [43] , and treatment with anti-IL1-β or IL-1Ra ameliorates the disease [36, 44] . Similarly, anti-TNF-α treatment inhibited CIA development [45] . Complete resistance to CAIA induced by our set of monoclonal antibodies by IL-1R and IL-1R TNFR deficient animals confirmed the earlier observations using IL-1R and TNFR deficient animals by Kagari et al. [32] , emphasizing the importance of these pro-inflammatory cytokines in the inflammatory phase of arthritis. Hence, the elucidation of the cytokine-mediated mechanisms involved in the joint inflammation should be studied in detail to uncover novel redundant systems in the inflammatory processes.
Contrary to the present findings, IL-4 did not affect the effector phase of arthritis induced by the GPI specific polyclonal sera, though IL-4 was found to be crucial for the development of arthritis in KBN model of inflammatory arthritis [46] . The observed difference between the present study and the anti-GPI system might be due to several reasons such as the genetic differences of the mice used, the predominance of γ1 antibodies present in the sera of KBN mouse model or the nature of antigen recognized by these antibodies [46] [47] [48] .
Hence, it is possible that there could be subtle differences between these two antibody mediated arthritis models. For example, FcγRIIb deficient mice are resistant to KBN sera induced arthritis but are highly susceptible to CAIA [23, 47] .
In the present study, we have observed that the arthritis developed in IL-4 gene It is also of interest to note that the level of IL-4 production is often low in the synovial fluid and tissue of RA patients [4] . It has been suggested that this lack of IL-4 may contribute to the uneven balance between destructive (Th1 cytokines) and regulatory mediators (Th2 cytokines) in the synovium of the RA process. On the contrary, results from the present study argue that the actual lack of IL-4 observed in RA patients could possibly be protecting the joints from the antibody-mediated inflammatory attack. In conclusion, the application of a simple Th1/Th2 paradigm to autoimmune diseases can mislead the effort to understand the pathogenic mechanisms. Furthermore, efforts to deviate the pre-existing inflammatory cytokines in RA patients by inducing anti-inflammatory cytokines or neutralizing pro-inflammatory cytokines should be critically evaluated before considering them for therapy. 
Materials and Methods
Animals
Purification of CII specific monoclonal antibodies
The CII specific hybridomas were generated and characterized as described in detail elsewhere [49, 50] . The anti-CII antibody producing hybridomas, M2139 and CIIC1 were cultured in ultra low bovine IgG containing DMEM Glutamax-I culture medium (Gibco BRL, Invitrogen AB, Sweden) with 100 mg/l of Kanamycin monosulfate (Sigma, USA). Monoclonal antibodies were generated in large scale as culture supernatant (SN) using integra cell line 1000 (CL-1000) flasks (Integra biosciences, Switzerland). Antibodies were purified using γ-bind plus affinity gel matrix (Pharmacia, Sweden) and Äkta purification system (Amersham Pharmacia Biotec AB, Uppsala, Sweden).
Briefly, culture SN was centrifuged at 12500 rpm for 30 min, filtered and degassed before applying to the gel matrix. Antibodies were eluted using acetic acid buffer at pH 3.0 and neutralized with 1 M Tris-Hcl, pH 9.0. The peak fractions were pooled and dialyzed extensively against PBS, pH 7.0 with or without azide. The IgG content was determined by freeze-drying and weighing the samples. The antibody solutions were filter sterilized using 0.2 µm syringe filters (Dynagard, Spectrum Laboratories, CA, USA), aliquoted and stored at -70° C until used. Amount of endotoxin content in the antibody solutions 19 prepared was found to be in the range of 0.02 -0.08 EU/ mg of protein as analyzed by limulus amebocyte lysate (Pyrochrome) method (Cape Cod Inc., MA, USA).
Passive transfer of antibodies
Arthritis was induced using CII specific monoclonal antibody cocktail as described earlier [26] . Briefly, the cocktail of CIIC1 and M2139 monoclonal antibodies was prepared by mixing equal concentrations of each of the sterile 
Clinical evaluation of arthritis
Mice were examined daily for the arthritis development for a minimum of 17 days or until the inflammation subsided. Scoring of animals was done blindly using a scoring system based on the number of inflamed joints in each paw, inflammation being defined by swelling and redness as described previously [51] . Scoring was recorded in the phalangeal joints (maximum of 1 point per digit, 5 points per paw), the metacarpus or metatarsus (5 points), and in the 20 wrist and ankle joints (5 points). Thus, the maximum score was 15/paw resulting in a peak of 60 for the total joint count.
Anti-IL-4 and anti-IFN-γ treatment
Rat monoclonal antibodies anti-IL-4 (11B11) and anti-IFN-γ (DB1) were purified from culture SN. Groups of mice were treated with either 1 mg of anti-IL-4, anti-IFN-γ, purified rat IgG, both anti-IL-4 and anti-IFN-γ or untreated.
Antibody treatment was done i.p. twice per week, starting from day -1 until day 13 (days -1, 2, 6, 9 and 13). All the mice were transferred with anti-CII mAb cocktail on day 0 i.v. and treated with 25 µg of LPS i.p. on day 5. Mice were monitored for arthritis development for 17 days and paw samples for histology were collected at the end of experiment.
Histological Preparations
Paws were dissected on the indicated days from each group of mice (3 -5 mice per group), fixed in 4% phosphate buffered paraformaldehyde solution (pH 7.0) for 24 hours, decalcified for 3-4 weeks in an solution containing EDTA, Polyvinylpyrrolidone and Tris-HCl, pH 6.95 followed by dehydration and embedding in paraffin. Sections of 6 µm were stained with safranin for detection of mast cells and newly formed cartilage. Proteoglycans were stained using toluidine blue.
For immunohistochemistry, paws were immediately frozen in OCT compound using isopentane on dry ice. The samples were stored at -70°C until cryosectioned at 10 µm at -30°C. Sections were stained with hematoxylin and eosin to visualize joint and cartilage destruction. Osteoclasts were detected using histochemical staining for tartarate-resistant acid phosphatase (TRAP) activity. Sections were counterstained with 0.1% aniline blue. Rat anti-mouse TNF-α (MP6-XT22) from BD pharmingen, CA, USA and biotinylated goat anti-rat IgG (DAKO A/S, Denmark), and goat anti-mouse IL-1β (R&D systems, Minneapolis, USA) and biotinylated horse anti-goat IgG (Vector Laboratories, CA, USA) were used as primary reagents for TNF-α and IL-1β respectively. Avidin peroxidase was used for detection. Diaminobenzidine staining was performed as previously described [52] and the slides were counter stained with Hematoxylin.
Statistical analyses
All the mice were included for calculation of arthritis susceptibility and arthritic animals were used for severity calculations. Mann Whitney or Kruskal Wallis and Chi Square tests were used for analyzing the severity and incidence 
